ClinicalTrials.Veeva

Menu

Ultrasonographic Response to Cervical and Upper Thoracic SNAG in Medial Epicondylitis, Randomized Clinical Trial

B

Beni-Suef University

Status

Enrolling

Conditions

Medial Epicondylitis

Treatments

Other: SNAG ( sustained natural apopheseal glide )

Study type

Interventional

Funder types

Other

Identifiers

NCT07187102
FMBSUREC/07092025/Ahmed

Details and patient eligibility

About

Aim of the work :

  1. To detect if there is any change would occur in the neovascularity and echogenicity after using cervical and upper thoracic SNAG or not in ME patients.
  2. To find the effect of cervical and upper thoracic SNAG on pain, function of upper extremities, grip strength in ME comparing with traditional treatment alone

Full description

medial epicondylitis(ME) of the elbow is a condition characterized by aggravation of pain in the outer part of the elbow during active wrist flexion , and presentation of pain on direct palpation of the medial epicondyle, or proximal muscle belly . Biomechanical and sensorimotor deficits can occur and adversely impact upper extremity function .These functional deficits may interfere with occupational tasks and activities of daily living The study's results: Measuring the changes that will be produced by using therapeutic growth of the cervical and thoracic vertebrae on the pathological changes that persist in the tendons of the tens of the tibialis cruciate ligaments in detecting excess weight resulting from the disease of the middle epicondyle, such as increased blood vessels in the tendon and decreased echogenicity of the tendon, in addition to measuring the changes that occurred in the extent of pain sensation and the extent of functional performance of the shoulder and elbow joints. Patients will be directly selected jointly according to the patient's specifications for the research and written consent will be obtained from the patient after a detailed explanation of the research steps and what is required of him. The vocal function of the tendon will be evaluated, with the exception of functional pain of the successful upper extremity and the strength of the hand muscles before and after the experiment.

Enrollment

60 estimated patients

Sex

All

Ages

35 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ranges from 35 to 50 years old in both sexes.
  • Patients with LE that diagnosed by orthopedist.
  • Pain onset is more than 3 months appear primarily with use or rest or in both, also , it appear with deep palpation of the medial epicondyle .

Exclusion criteria

  • • Rheumatoid Arthritis .

    • Skin infection.
    • History of previous elbow surgery.
    • Any pathology in the shoulder joint.
    • Neurologic deficit in upper extremity.
    • Cervical disc prolapse and radiculopathy C5,6.
    • Dislocation of elbow joint.
    • Recent fractures of upper extremity.
    • Arthrosis of the radiohumeral joint.
    • Osteochondritis dissecans.
    • Osteonecrosis.
    • Plica synovialis.
    • Participants receiving other treatment, in the form of physical therapy or medication, for the duration of the study that may interfere with the results of this study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

experimental group
Experimental group
Description:
Participants will receive the physiotherapy SNAG plus traditional treatment program (4weeks, supervised sessions 3 times per week )
Treatment:
Other: SNAG ( sustained natural apopheseal glide )
control group
Other group
Description:
Participants will receive the physiotherapy traditional treatment program (4weeks, supervised sessions 3 times per week )
Treatment:
Other: SNAG ( sustained natural apopheseal glide )

Trial contacts and locations

1

Loading...

Central trial contact

Sahar M Abdelmutilibe, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems